Background: Gastric banding is a well established weight reduction operation that is effective in the treatment of severe obesity. Its metabolic and endocrine mechanisms of action, however, remain unclear. The aim of this study was to establish a rat model of gastric banding that would replicate the procedure performed in human obese patients.
Introduction
The prevalence of obesity is accelerating worldwide. The obesity epidemic is recognized by the World Health Organization as one of the top 10 global health problems. 1 Obesity is associated with increased prevalence of hypertension, dyslipidemia, diabetes type 2, cardiovascular disease, non-alcoholic steatohepatitis, sleep apnea, osteoarthritis and depression. 1 The high morbidity rate is costly, both for the individual and the health-care system. [2] [3] [4] Weight loss improves or resolves the co-morbidities. 5, 6 Bariatric surgery, by restrictive or malabsorptive methods, is the only treatment sustaining weight loss. 5 Gastric banding, a restrictive type of bariatric surgery, is a well established weight reduction operation, 7 although the precise mechanisms leading to weight reduction are not fully understood. 5 In general, bariatric surgery is considered to induce weight loss by reduction of gastric capacity and by decrease in appetite, both leading to diminished food intake. 2 If and how such a surgical procedure interferes with appetite and satiety is difficult to demonstrate in humans. Thus far, there are no experimental studies to support this interpretation. Further investigations on the sustained weight loss that follows gastric banding may enable a better understanding of the appetite-satiety pathways, and also the development of new and more successful medical treatments of obesity.
There is a need for an animal model that will allow the testing of putative mechanisms whereby surgical procedures lead to a decrease in food intake and body weight, that are known to be regulated by the interaction between the gastrointestinal tract and the hypothalamus. 2 We have, therefore, investigated whether gastric banding would lead to weight loss in Wistar rats in a way that would resemble what occurs in the human after gastric banding. In the current preliminary report using a small number of rats, we document that there are significant differences between rats submitted to gastric banding and sham-operated controls with regards both to food intake and body weight.
Materials and Methods
Nine male Wistar rats (125-150 g) purchased from the commercial breeder Charles River, Barcelona, were maintained in individual cages under controlled temperature (21-23˚C), humidity, and light (12h light, 12h dark, lights on at 0800 h) with ad libitum access to standard rat chow (A04, Panlab, s.l., Barcelona, Spain) and tap water. All procedures were approved by the local Ethics Board for Animal Research, and followed the European Union laws on animal protection (86/609/EC). Animals were acclimatized to the local facilities for 7 days before surgery and only healthy growing animals were used in the experiments.
After an overnight 12h fast, rats were anesthetized by intra-peritoneal injection of a mixture of ketamine 60 mg/kg (Imalgene 1000, Merial, Portugal) and xilazine 12 mg/kg (Rompun, Bayer, Portugal) according to body weight. A midline abdominal incision was made, and the stomach was exposed. For the gastric banding, the surgical technique consisted in placing a 14-mm long and 2-mm wide silicone band, custom-made, at the glandular portion of the gastric fundus immediately below the rumen, partially restraining the stomach volume and creating upper and lower pouches in the stomach. To keep the band from sliding and from dislocation, two vertical stitches (Prolene 5/0, Ethicon, Edinburgh) were placed in the anterior stomach wall near the lesser and the greater curvatures ( Figure 1A  and B ). The abdominal wall was closed with reabsorbable sutures (Vycril 3/0, Ethicon, Edinburgh).
As controls, a sham-operated group of four rats was included. These rats were submitted to the same procedure described above, except for the placing of a non-restraining band in the same location which was removed immediately before closure of the abdominal wall. Both groups of animals were given 5 ml sterile warmed saline subcutaneously to avoid dehydration and allowed to recover spontaneously from anesthesia and the surgery.
Rats were returned to their home cages which contained a pre-weighed amount of food. Body weight was measured daily at 0900 h using a scale (Monobloc, Metterr, Toledo, Spain), recording to the nearest 1 g and the remaining food in the hopper was reweighed at the same time using a scale (Kern, KB 5000-1, Balingen, Germany) recording to the nearest 0.1 g, which allowed daily food intake to be calculated.
Results are shown as means ± SE, unless otherwise specified. Unpaired t-test was used for comparison of the means between the two unpaired treatment groups; P<0.05 was considered to be statistically significant.
Results
Male Wistar rats were submitted either to gastric banding (n=5) or sham gastric banding (n=4), as described above, and were followed for 21 days after the surgical procedure. All animals submitted to sur-Experimental Gastric Banding in the Rat Obesity Surgery, 16, 2006 49 Figure 1A . Surgical placement of a gastric band around the stomach of a Wistar rat, just below the rumen of the animal. Figure 1B . The stomach of a Wistar rat after being submitted to gastric banding.
